Table 4.
Systemic inflammatory biomarkers in relation to tumor localization.
| Biomarker | Total (n = 122) | p | |
|---|---|---|---|
| Right-Sided (n = 51) No. (%) | Left-Sided (n = 71) No. (%) | ||
| NLR | |||
| <3 | 34 (66.7) | 31 (44.3) | |
| ≥3 | 17 (33.3) | 39 (55.7) | 0.015 |
| PLR | |||
| <169 | 27 (52.9) | 26 (37.1) | |
| ≥169 | 24 (47.1) | 44 (62.9) | 0.085 |
| SII | |||
| <730 | 30 (58.8) | 28 (40.0) | |
| ≥730 | 21 (41.2) | 42 (60.0) | 0.041 |
| hs-PCR | |||
| <13.1 | 29 (58.0) | 39 (60.0) | |
| ≥13.1 | 21 (42.0) | 26 (40.0) | 0.829 |
| LDH | |||
| ≤UNL | 16 (31.4) | 21 (29.6) | |
| >UNL | 35 (68.6) | 50 (70.4) | 0.832 |
NLR, neutrophil-to-lymphocyte ratio; PLR, platelet-lymphocyte ratio; SII, systemic immune-inflammation index; hs-PCR, high-sensitivity C-reactive protein; LDH, lactate dehydrogenase; UNL, upper normal limit.